Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
975.47%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 17Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information
Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLYELL IMMUNOPHARMA INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LYEL - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 517K | 975.47% | $ 53K |
| 3/31/2025 | $ 680K | 1172.41% | $ 58K |
| 12/31/2024 | $ 464K | 760.66% | $ 61K |
| 9/30/2024 | $ 445K | 706.35% | $ 63K |
| 6/30/2024 | $ 581K | 1075.93% | $ 54K |
| 3/31/2024 | $ 1.18M | 1739.71% | $ 68K |
| 12/31/2023 | $ 2.69M | 2066.15% | $ 130K |
| 9/30/2023 | $ 7.24M | 14.93% | $ 48.5M |
| 6/30/2023 | $ 9.84M | 20.29% | $ 48.48M |
| 3/31/2023 | $ 16.08M | 19.09% | $ 84.19M |
Key Performance Insights, Last 5 Years
- LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) CapEx % stands at 663.76%.
- Over the past 5 years, LYELL IMMUNOPHARMA INC's average CapEx % has been 666.74%.
- The median CapEx % for LYELL IMMUNOPHARMA INC during this period was 651.85%
- LYELL IMMUNOPHARMA INC reached its highest CapEx % over the past 5 years at 2066.15%.
- The lowest CapEx % recorded by LYELL IMMUNOPHARMA INC in the same timeframe 14.93%
LYELL IMMUNOPHARMA INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for LYELL IMMUNOPHARMA INC is calculated as follows: CapEx [ $ 51.48M ] / Revenues [ $ 7.76M ]
(=) CapEx % [ 663.76% ] LYEL - Capital Expenditures Margin, Last 5 years
14.93%
Minimum
Sep 30, 2023
2066.15%
Maximum
Dec 31, 2023
666.74%
Average
651.85%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |